{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:41:56Z","timestamp":1783539716891,"version":"3.55.0"},"reference-count":30,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1629,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1365-2362.2011.02502.x","type":"journal-article","created":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T02:46:28Z","timestamp":1300416388000},"page":"1071-1076","source":"Crossref","is-referenced-by-count":33,"title":["Predictors of indeterminate IFN-\u03b3 release assay in screening for latent TB in inflammatory bowel diseases"],"prefix":"10.1111","volume":"41","author":[{"given":"Pavol","family":"Papay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Eser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Frantal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Primas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Miehsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sieglinde","family":"Angelberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"Novacek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mikulits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Vogelsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Reinisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,17]]},"reference":[{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB1|cit1","first-page":"49","article-title":"Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States","volume":"54","author":"Mazurek","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/rheumatology\/kei103","article-title":"British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-\u03b1 treatments","volume":"44","author":"Ledingham","year":"2005","journal-title":"Rheumatology"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"Rahier","year":"2009","journal-title":"J Crohns Colitis"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy","volume":"2","author":"Mow","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","article-title":"Attenuated response to purified protein derivate in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis","volume":"64","author":"Ponce de Leon","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-g assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence based comparison of commercial interferon-gamma release assays for detecting active tuberculosi-a meta-analysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/14737159.6.3.413","article-title":"New tools and emerging technologies for the diagnosis of tuberculosis: part 1. Latent tuberculosis","volume":"6","author":"Pai","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel diseases","volume":"103","author":"Schoepfer","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon \u03b3 assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ibd.21329","article-title":"QunatiFERON TB gold testing for tuberculosis screening in inflammatory bowel disease cohort in the United States","volume":"17","author":"Qumseya","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ibd.21427","article-title":"Factors impacting the results of interferon-\u03b3 release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases","volume":"17","author":"Papay","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-9-207","article-title":"Performance of the tuberculin skin test and interferon-\u03b3 release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population","volume":"9","author":"Kim","year":"2009","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","article-title":"Routine hospital use of a new commercial whole blood interferon- \u03b3 assay for the diagnosis of tuberculosis infection","volume":"172","author":"Ferrara","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","article-title":"Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study","volume":"367","author":"Ferrara","year":"2006","journal-title":"Lancet"},{"issue":"Suppl I","key":"10.1111\/j.1365-2362.2011.02502.x-BIB17|cit17","first-page":"i1","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2019s disease","volume":"55","author":"Caprilli","year":"2006","journal-title":"Gut"},{"issue":"Suppl I","key":"10.1111\/j.1365-2362.2011.02502.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2005.081950a","article-title":"European evidence based consensus on the diagnosis and management of Crohn\u2032s disease: definitions and diagnosis","volume":"55","author":"Stange","year":"2006","journal-title":"Gut"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2362.2009.02234.x","article-title":"A catalogue of reporting guidelines for health research","volume":"40","author":"Simera","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"10","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"Suppl A","key":"10.1111\/j.1365-2362.2011.02502.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular, and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"A507","DOI":"10.1016\/S0016-5085(03)82569-6","article-title":"Interobserver agreement analysis of a national Inflammatory Bowel Disease Information System (IBDIS)","volume":"124","author":"Oefferlbauer-Ernst","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMcp021045","article-title":"Latent tuberculosis infection","volume":"347","author":"Jasmer","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-4731(88)90080-5","article-title":"Glucocorticoid effects on the production and actions of immune cytokines","volume":"30","author":"Guyre","year":"1988","journal-title":"J Steroid Biochem"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1749-6632.1998.tb11129.x","article-title":"Azathioprine, mycophenolate mofetil, and methotrexate specifically modulate cytokine production by T cells","volume":"859","author":"Hildner","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00040007","article-title":"Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients","volume":"30","author":"Kobashi","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1183\/09031936.00075008","article-title":"Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice","volume":"33","author":"Kobashi","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-7-56","article-title":"Latent tuberculosis in HIV positive, diagnosed by the M.tuberculosis specific Interferon \u03b3 test","volume":"7","author":"Brock","year":"2006","journal-title":"Respir Res"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1086\/597351","article-title":"Detection and prediction of active tuberculosis disease by a whole-blood interferon- \u03b3 release assay in HIV-1-infected individuals","volume":"48","author":"Aichelburg","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1365-2362.2011.02502.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365529309096037","article-title":"Review: assessment of disease severity and activity in inflammatory bowel disease","volume":"28","author":"Kjeldsen","year":"1993","journal-title":"Scand J Gastroenterol"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2011.02502.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2362.2011.02502.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T00:58:30Z","timestamp":1625360310000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2011.02502.x"}},"subtitle":["PREDICTORS OF INDETERMINATE IFN-\u03b3 RELEASE ASSAY"],"short-title":[],"issued":{"date-parts":[[2011,3,17]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02502.x","relation":{},"ISSN":["0014-2972"],"issn-type":[{"value":"0014-2972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,17]]}}}